| Literature DB >> 24734047 |
Juliana M A Agostinho1, Andressa de Souza2, Ruben P Schocken-Iturrino3, Lívia G Beraldo1, Clarissa A Borges1, Fernando A Avila3, José M Marin4.
Abstract
Pyometra is recognized as one of the main causes of disease and death in the bitch, and Escherichia coli is the major pathogen associated with this disease. In this study, 70 E. coli isolates from the uteri horn, mouth, and rectum of bitches suffering from the disease and 43 E. coli isolates from the rectum of clinically healthy bitches were examined for the presence of uropathogenic virulence genes and susceptibility to antimicrobial drugs. DNA profiles of isolates from uteri horn and mouth in bitches with pyometra were compared by REP, ERIC, and BOX-PCR. Virulence gene frequencies detected in isolates from canine pyometra were as follows: 95.7% fim, 27.1% iss, 25.7% hly, 18.5% iuc, and 17.1% usp. Predominant resistance was determined for cephalothin, ampicillin, and nalidixic acid among the isolates from all sites examined. Multidrug resistance was found on ∼ 50% pyometra isolates. Using the genotypic methods some isolates from uteri, pus, and saliva of the same bitch proved to have identical DNA profiles which is a reason for concern due to the close relationship between household pets and humans.Entities:
Year: 2014 PMID: 24734047 PMCID: PMC3966421 DOI: 10.1155/2014/979584
Source DB: PubMed Journal: Int J Microbiol
PCR: genes, primer sequences, and amplicons size.
| Genes | Primer sequence (5′–3′) | Size (bp) | Reference |
|---|---|---|---|
|
| TGCAGAACGGATAAGCCGTGG | 508 | Siqueira et al., 2009 [ |
|
| |||
|
| TACCGGATTGTCATATGCAGACCGT | 602 | Siqueira et al., 2009 [ |
|
| |||
|
| GGCCACAGTCGTTTAGGGTGCTTACC | 450 | Johnson et al., 2008 [ |
|
| |||
|
| ATGCTACTGTTTCCGGGTAGTGTGT | 1000 | Siqueira et al., 2009 [ |
|
| |||
|
| CAGCAACCCGAACCACTTGATG | 323 | Johnson et al., 2008 [ |
|
| |||
|
| GGAATGTGGTGATTACTCAAAGG | 562 | Siqueira et al., 2009 [ |
Number of E. coli isolates obtained from different sampling sites of bitches with pyometra.
| Bitch | Sites of sample collection | ||
|---|---|---|---|
| Uteri pus ( | Saliva ( | Feces ( | |
| 1 | 3* | 5 | 5 |
| 2 | 5 | 5 | 5 |
| 3 | 5 | 5 | 5 |
| 4 | 5 | 5 | 0 |
| 5 | 4 | 5 | 0 |
| 6 | 3 | 1 | 4 |
*Number of E. coli isolates.
Prevalence of genes encoding virulence factors in E. coli isolates from uteri horn (pus), saliva, and feces from 6 bitches suffering pyometra and from feces of 6 clinically healthy bitches.
| Gene | Bitches with pyometra | Healthy bitches | ||
|---|---|---|---|---|
| Uteri pus ( | Saliva ( | Feces ( | Feces ( | |
|
| 23 (92.0%) | 26 (100.0%) | 18 (94.7%) | 41 (95.3%) |
|
| 1 (4.0%) | 5 (19.2%) | 7 (36.8%) | 9 (20.9%) |
|
| 4 (16.0%) | 5 (19.2%) | 9 (47.3%) | 7 (16.2%) |
|
| 5 (20.0%) | 4 (15.3%) | 3 (15.7%) | 9 (20.9%) |
|
| 3 (12.0%) | 5 (19.2%) | 11 (57.8%) | 6 (13.9%) |
Linkage of virulence genes in isolates of E. coli from canine pyometra and feces of healthy bitches.
| Number of virulence genes per isolate | Number of | |||
|---|---|---|---|---|
| Bitches with pyometra | Healthy bitches | |||
| Uteri pus | Saliva | Feces | Feces | |
| None | 1 | 0 | 1 | 0 |
| 1 | 16 | 15 | 7 | 23 |
| 2 | 6 | 5 | 1 | 13 |
| 3 | 1 | 4 | 3 | 5 |
| 4 | 0 | 2 | 5 | 2 |
| 5 | 1 | 0 | 2 | 0 |
Prevalence of antimicrobial resistance among 70 E. coli isolates from 6 bitches suffering pyometra.
| Antimicrobial drug | Uteri (pus) | Mouth (saliva) | Rectum (feces) |
|---|---|---|---|
| Norfloxacin | 0* (0.0%)** | 5 (19.2%) | 1 (5.2%) |
| Cefoxitin | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Tobramycin | 0 (0.0%) | 7 (26.9%) | 6 (31.5%) |
| Ciprofloxacin | 2 (8.0%) | 1 (3.8%) | 2 (10.5%) |
| Gentamicin | 3 (12.0%) | 6 (23.0%) | 5 (26.3%) |
| Ceftriaxone | 5 (20.0%) | 5 (19.2%) | 7 (36.8%) |
| Tetracycline | 8 (32.0%) | 22 (84.6%) | 12 (63.1%) |
| Amikacin | 10 (40.0%) | 10 (38.4%) | 11 (57.8%) |
| Nitrofurantoin | 10 (40.0%) | 16 (61.5%) | 15 (78.9%) |
| Ampicillin | 14 (56.0%) | 22 (84.6%) | 9 (47.3%) |
| Nalidixic acid | 14 (56.0%) | 22 (84.6%) | 8 (42.1%) |
| Cephalothin | 17 (68.0%) | 17 (65.3%) | 13 (68.4%) |
*Number of isolates; **percentage.
Antimicrobial resistance (percentage) and distribution of number of resistant phenotypes among the E. coli commensal isolates from feces of bitches with pyometra and healthy bitches.
| Antimicrobial drugs | Feces | |
|---|---|---|
|
Bitches with Pyometra ( | Healthy bitches ( | |
| Ampicillin | 47.3% | 41.1% |
| Cephalothin | 68.4% | 35.2% |
| Ceftriaxone | 36.8% | 0.0% |
| Tetracycline | 63.1% | 41.1% |
| Gentamycin | 26.3% | 11.7% |
| Amikacin | 57.8% | 17.6% |
| Nalidixic acid | 42.1% | 17.6% |
| Ciprofloxacin | 10.5% | 0.0% |
|
| ||
| Number of resistant phenotypes | Number of | |
|
| ||
| 0 | 2 | 19 |
| 1 | 3 | 8 |
| 2 | 4 | 8 |
| 3 | 2 | 3 |
| 4 | 1 | 3 |
| 5 | 4 | 2 |
| 6 | 2 | 0 |
| 7 | 1 | 0 |
Figure 1Dendrogram constructed by UPGMA method using genetic distances obtained by REP-PCR analysis of E. coli isolates from bitches suffering pyometra: 2/18-bitch 2 isolate 18 from uteri pus; 2/36-bitch 2 isolate 36 from saliva; 2/41-bitch 2 isolate 41 from saliva; 3/51-bitch 3 isolate 51 from saliva; 3/59-bitch 3 isolate 59 from uteri pus; 4/65-bitch 4 isolate 65 from saliva; 4/71-bitch 4 isolate 71 from uteri pus.